This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.. Active years: 2016-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2020
Title: Mohamad Hussein: Innovator in Myeloma Monitoring
Introduction
Mohamad Hussein is a notable inventor based in Odessa, FL (US). He has made significant contributions to the field of medical diagnostics, particularly in the monitoring of multiple myeloma. With a total of 2 patents, his work focuses on innovative methods that enhance the understanding and management of this complex disease.
Latest Patents
Hussein's latest patents revolve around "Methods and materials for monitoring myeloma using quantitative mass spectrometry." These inventions concern the diagnosis, monitoring, and prognosis of multiple myeloma and other conditions associated with antibody production in individuals. The methods utilize mass spectrometry for the quantitative monitoring and detection of antibodies produced by plasma cells. This innovative approach allows for the diagnosis and monitoring of multiple myeloma, monoclonal gammopathy, and other immunological or hematological conditions. Additionally, the invention enables the detection and quantification of other biological markers, such as serum albumin and beta-2-microglobulin, in conjunction with antibody detection. This comprehensive method provides a more accurate diagnosis and prognosis based on the levels detected.
Career Highlights
Mohamad Hussein is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc. His work at this esteemed institution underscores his commitment to advancing cancer research and improving patient outcomes through innovative diagnostic methods.
Collaborations
Hussein collaborates with esteemed colleagues, including John Matthew Koomen and Elizabeth Renee Remily. These partnerships enhance the research and development of his innovative methods, contributing to the broader scientific community.
Conclusion
Mohamad Hussein's contributions to the field of myeloma monitoring through his patented methods exemplify the impact of innovation in medical diagnostics. His work not only advances scientific understanding but also holds the potential to improve patient care significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile